Table 3.

Agreement (concordance) and validity of investigations.

Variable testedmPAP ≥ 25 mmHgmPAP ≥ 25 mmHgmPAP, ≥ 21 mmHgILDLVD
Reference investigationRHCRHCRHCChest CT scanTTE
No. subjects1010102727
Diagnostic methodCPETTTECPETCPETCPET
Observed concordance80%70%90%78%96%
Sensitivity (CI 95%)0.86 (0.42–1.0)0.67 (0.22–0.96)0.89 (0.52–1.0)0.78 (0.52–0.94)1.00 (0.29–1.0)
Specificity (CI 95%)0.67 (0.094–0.99)0.75 (0.19–0.99)1.0 (0.025–1.0)0.78 (0.40–0.97)0.96 (0.79–1.0)
PPV (CI 95%)0.86 (0.42–1.0)0.8 (0.28–0.99)1.0 (0.63–1.0)0.88 (0.62–0.98)0.75 (0.19–0.99)
NPV (CI 95%)0.67 (0.094–0.99)0.6 (0.15–0.95)0.5 (0.013–0.99)0.64 (0.31–0.89)1.0 (0.85–1.0)
McNemar, p value0.481.001.000.681.00
  • P value for McNemar’s test with Yates’ continuity correction (comparisons between diagnostic method and its reference investigation). mPAP: mean pulmonary arterial pressure; ILD: interstitial lung disease; LVD: left ventricular dysfunction; RHC: right heart catheterization; CT: computed tomography; TTE: transthoracic echocardiogram; CPET: cardiopulmonary exercise test; PPV: positive predictive value; NPV: negative predictive value.